Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses the impact of reduced intensity conditioning for allogeneic stem cell transplantation (alloSCT) in acute myeloid leukemia (AML). Prof. Nagler first explains the high toxicity associated with previous forms of myeloablative conditioning, and then goes on to comment on how reduced intensity conditioning has improved the efficacy and safety of transplantation over the years. This interview took place at the XIII Eurasian Hematology-Oncology Congress (EHOC) held in Istanbul, Turkey.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.